Presented by: David Brady, ND
Autoimmune disease is growing at epidemic proportions. Standard interventions are based on symptom control and immune suppression. This presentation will review a proactive integrative, systems biology, approach for the integrative physician to address disease prediction, prevention and treatment, including various evidence-based modalities. Presentation elements will include an exploration of the role of the GI microbiota, food immune reactions, stealth infections, and molecular mimicry in autoimmune disease pathogenesis and how these may serve as leverage points for clinical interventions. The hygiene hypothesis and changes in early environmental antigen exposure will also be explored.
In today’s healthcare industry, the integrative healthcare model can take many forms. A care team may include interdisciplinary members of one clinic, or it may include a network of different practitioners in one community.
In this case study collection, we review a chronic pain patient and how she interacts with a collaborative integrative healthcare team to heal and achieve optimal health and balance. Featuring expert perspectives from Kellie Blake, RD, LD, IFNCP; Catherine Darley, ND; Joel Kreisberg, DC, PCC, CCH, NBC-HWC; Julie Luzarraga, LICSW, DCSW; and Robert Silverman, DC, DACBN, DCBCN, MS, CCN, CNS, CSCS, CIISN, CKTP, CES, HKC, FA, the authors, acting as members of the patient's care team, walk the reader through integrative collaboration in practice.
Presented by: Kenneth Pelletier,
Biology is no longer destiny. Our DNA doesn’t determine our health and disease prospects, as geneticists once believed. According to the new science of epigenetics, the vast majority of our genes are fluid and dynamic—and their expression is shaped by what we think and what we do. Our genetic profile may signal an inherited vulnerability to a disease, but our choices and behaviors determine whether these genes will be switched on or off. This session presented by a renowned pioneer in integrative medicine reveals that each of us can change our genes to create optimal health and longevity.
Presented by: David Fogel, MD; Mark Hyman, MD; Lorilee Schoenbeck, ND; and John Weeks
Clinical leaders in integrative, functional, and naturopathic medicine report conceptual aligned with the medical industry’s move from “volume to value.” Enhancing patient experience, saving costs, raising practitioner satisfaction and bettering health—touchstones each of value-based medicine—are friendlier measures than outproducing surgeons. Might functional, integrative and naturopathic pilots in such a “value-based care” environment draw the media, clout, policy-interest, and investment to prove these as optimal models of care?
Presented by: Robert Rountree, MD
The clinicians' task is not to simply extend life, but to decrease or prevent disability or prolonged morbidity. That task has been made easier by recent advances in genomics research and cellular biology. By understanding the underlying molecular events and disrupted signaling pathways thought to be responsible for senescence, disease, and aging, we can determine the most effective strategies to maintain optimal performance and zestful health. This presentation will explore the various factors that can activate or downregulate the primary intracellular biochemical pathways associated with aging and longevity, including AMPK/sirtuins, mTOR, and Nrf2/ARE. We will then review the literature regarding lifestyle practices and dietary supplements that can potentially modulate those pathways in beneficial ways.
Patients need support when it comes to adopting and sustaining healthy behaviors. Over half of the adults in the United States have at least one chronic disease and 25 percent have two or more. Yet, providers seldom learn how to counsel patients on healthy living and, even if they do, they have limited time to guide patients to make lasting change.
Presented by: Gerald Lemole, MD
“The Role of Lymphstasis in Atherogenesis” appeared in the Annals of Thoracic Surgery in the March 1981 issue. It examined the significance of lymphatic involvement in arteriosclerosis. Presently, the underlying premise of the original paper is reviewed with its relationship to recent information regarding reverse cholesterol transport.
Small Intestine Bacterial Overgrowth - Key Elements Regarding Testing and Intervention
The current state of medical therapy for cognitive decline and dementia is focused on single drug therapy. This approach has yielded unsatisfactory outcomes. A Functional Medicine approach utilizes a model of evaluation and therapeutics that is an assessment of the bioterrain of the unique individual in relation their individual genetics interaction with their environmental exposome to assess and provide a personalized, precision approach to brain health based on each individual’s genetics, the unique epigenetic triggers, the exacerbating hormone and nutritional imbalances as well as the deficiencies in optimal assimilation and biotransformation. Potential hormone imbalances, nutrient deficiencies combined with unique toxic insults may potentiate these processes leading to poor cognitive outcomes.